Lung Disease of Prematurity
📧 Sign up to get email alerts when something new happens for Lung Disease of Prematurity.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-04-04FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
The FDA approved a supplemental application for Synagis (palivizumab) filed by Swedish Orphan Biovitrum AB (publ).